1. Home
  2. CADL vs CRNT Comparison

CADL vs CRNT Comparison

Compare CADL & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$11.85

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Ceragon Networks Ltd.

CRNT

Ceragon Networks Ltd.

HOLD

Current Price

$2.11

Market Cap

213.6M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
CRNT
Founded
1999
1996
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
213.6M
IPO Year
2021
2000

Fundamental Metrics

Financial Performance
Metric
CADL
CRNT
Price
$11.85
$2.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
2
Target Price
$19.00
$3.50
AVG Volume (30 Days)
1.1M
272.1K
Earning Date
05-14-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
N/A
EPS
N/A
N/A
Revenue
$125,000.00
N/A
Revenue This Year
N/A
$9.11
Revenue Next Year
N/A
$6.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$1.85
52 Week High
$14.00
$3.29

Technical Indicators

Market Signals
Indicator
CADL
CRNT
Relative Strength Index (RSI) 48.82 49.91
Support Level $9.40 $2.09
Resistance Level $14.00 $2.14
Average True Range (ATR) 0.71 0.05
MACD -0.18 0.01
Stochastic Oscillator 46.56 73.33

Price Performance

Historical Comparison
CADL
CRNT

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About CRNT Ceragon Networks Ltd.

Ceragon Networks Ltd is a wireless transport specialist, providing wireless connectivity solutions to markets globally across various industries, including wireless (mobile) network service providers and private networks, enabling them to build new networks and evolve networks towards 4G and 5G services. Its portfolio mainly comprises the IP-20 and IP-50 product series, including integrated multi-technology radio units operating across frequencies from 4 GHz to 86 GHz, as well as single-radio devices used for wireless data transport. Additionally, the company offers turnkey services including: network and radio planning, site survey, installation, network auditing and optimization, and more. Geographically, it derives maximum revenue from India, followed by North America and other regions.

Share on Social Networks: